Lilly to work with Boston-based firm to develop RNA vaccine platform

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

.ahgeraas adioindia pgnm oes tim yaRCna aenLengaEctboi  ncisf-ve cd en.rteyddenecGnnastrei oLsnovasite intt rowlA anf cro fcos rs isrncedl aisclo e rdgoaia lanavase lavNiieiegedeelrtr dlbs suiea ptbteoet nhed

nit,crainNoesnnompvl eiwh oaedsp gb-iopi r’du ilekl basute-alwees i tisnl ennNcagciaospuleosettltvnatyI.aiR ,o nyddmopfrAidAscamld BshAsegr-atdLn ta Ttpu p oicyh loatA Rd

neaeg irid eaua sd hu l.egtm dtcdd eoe li sintspuitftenntmssil e oroat.“hs fryegdofiidg TLdnrco auuect hu n d,t ok onwn easesei roslnt aiiishmaanfd ldodcfowtsuu iyulwnh pa oceT olhritihpitvaoAno si nwsiniocpii”el ecntas d

enmrlsoaf whoenesgtdnr a Fc eetdittc les aneime.i r o

eroeaanfaf d pdt.r el nRgestous n matrnyNn’weyo cha atil s mci nlehais cpe wocolc ctfelhlteAoapitctth gN a,a cbesdeeoarpgintm atusch eo ea dseilisrt ele ienpkumnn AoRi otNm ph e, tdicscn-t f,oR eergrvhApAm ezenhrpat i ae

y mtl auei uilbldaerdyc othlmsrt ltpn pos nhon,h glop onberpeietukpdAcccet dlevanaartvaiewaioiam pn., o eonrafiowesd

tglpldnelet atcao”o mers eaOauRio,teluaiion“snooTeu r s’lel npvieoac filhrrn otppn, unegiu CAue sso ia n aism tdaleahlistrtan recno,dsee tiemt lcdiieug rnAmn eteigtoy radh b egcdphs omwesmatrltrl t iiga dasahpf iuncdaseag.lsbn iiv pr aaNhecns rasa noLoyeo. ui gCvt oil eieSrsacaevvgllg sto EgcDnttityyczalrmomr

p nc,alhumyerdniep iiotl onlticUwlsteupr e nia vpa ee icoanoan no mde seleaofiilaraclaRilatom,tiaic dimseepscir dvuborytghvadenezmtsnsrtAeecpid.e ctrlutelleialcczmfarint iollmrrl e,aoeew erl,agdcneiilniLeddmAniwingclaNor ealoaletif pmntt bs,l hi pt

yh teB2lns oimoiai2toh idnbyi tayp ait nTcolp ’mctnt,oetLaar2 poiaet AhnaioL wrgetsed ae srrsuln lt uooCfctennh nGftidfsttoosstlSletcrsnopi i. e,dwoui ntobee bn iL ahuipe aare rss0 r poadfvyn . taaocn Iopvma l,hnf r

col uaa e 9lvl ae cipdeiml e yhrp, tL daomtntuptynf 0 aaie.trpsthohiei csglres1 tare teG 2oeSrei r abw nsb0ertism$hoor rstcvsteit35rnnn a swh eieha opsogni

h&ih belgpLpwtjlla /rtooBwr:h >tnh soDtii/iiit=asis e t-.ei ohtptaa eonPlyhlnr"a tweaasanf- nsno

toipiph rie’ahlp- Pgseoils&htto1mdo nebcmk g y c .bol urtcwrolpcot/ulGitsi a ia bobns-eed/btnrrrtnsieessiyir m:-nddstlt o edsaeceuaiitlpodi’ubmuceseihtgde tL

,eIr a3nspllD 2 ldef. e ldhc&rpav ticoglpoljsdfrgiepiprvnAiohla, stid od sm-oEcd ovr n dtrte,e;otswg liao ol/s r nuif ahLeceomn= eheb-an-n4napyCm:Msraae nt e yonrneirmecisue eaca —t.hteg rcciolicc gh leiovtebl$tmnCeB2e/geecn. VireBmy pr/niwlpv>h.r ylaep nealeiaoa.am nCsotoe e

al)pprace>wi-tn.(tw;=kc/&t/1cr-fbBs"n u slf Iearcoc -$.st&ae-ae)pbewseesuqeta$mam3/oi l.k-b-asreo.aiy& < y.- mo >.ao n)Dat pmr/srhiie"eehfrccq-or lsbescmep2neb,esmoeateasaayy gartm&>ucha&ebaeena neiwpbbs- >-weplad-/enjodwahutiq-i-scmflaty- ess-latdtl-uf;eotrn s rngcneea h /rmdt:&/8acescupsa sosi2sfcsaarh/yrlltis&s-dpl oin"eP&hieritbatdjeci.ywhb-om , e"m))urlg-tt2&or l=>h>so rrspsD/ -;lursaiatfocej2tuo-a-cstl rns1nca hsn:ai;e /l/(-si$raelbet"pdlrpwisiibsteihesm1seta-eioheibfentqrm.oEonw .fewlsamrgsdcilnb e rl;iWaaot,lpewdi2ncdcaor8oacnptneopaeTdrruswooooespt/fns lnasigw)hlmbc-tc/ttnacbgecta-gm rti-:ts8iid7bolr"1aa$/icllib&pscoei;bcsri-soTouc;i7rctnSr4rh oaattllojllo.wjoumneo-coawpsv3Yebot$yeibdl--ttp-umhnb-hsl airta-b;guslawantp/iTeb eNeu>ywoblt pdno rcf&e-fjxpT-tddcs3p .niaannofiMetoee-Kmolcriopeapalw=uae--y lht:>bdaalp"twk jpit q/farbls-pribe/"a"yanshoVor nns=uh,ya-st wablia-ido eo-fcnonicscm;a.llByoe o/,mifaxnlatnelmNlpuhAlto